Lineage Cell Therapeutics, Inc. Amortization of Intangible Assets
Lineage Cell Therapeutics, Inc. (LCTX) reported Amortization of Intangible Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-05
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $0.00.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for fiscal 2024 was $22.00K, a 83.08% decline from fiscal 2023.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for fiscal 2023 was $130.00K, a 10.34% decline from fiscal 2022.
- Lineage Cell Therapeutics, Inc. amortization of intangible assets for fiscal 2022 was $145.00K, a 30.95% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-05 | $22.00K 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $22.00K 10-Q · filed 2025-11-06 | $54.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | $22.00K 10-Q · filed 2025-08-12 | $54.00K derived: sum of 3 quarters · filed 2026-03-05 | $87.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $22.00K 10-K · filed 2026-03-05 | $54.00K derived: sum of 2 quarters · filed 2026-03-05 | $87.00K derived: sum of 3 quarters · filed 2026-03-05 | $119.00K derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $65.00K derived: sum of 2 quarters · filed 2025-03-10 | $97.00K derived: sum of 3 quarters · filed 2025-03-10 | $130.00K 10-K · filed 2025-03-10 | ||||
| 2023-09-30 | $33.00K 10-Q · filed 2024-11-14 | $65.00K derived: sum of 2 quarters · filed 2024-11-14 | $98.00K 10-Q · filed 2024-11-14 | $130.00K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $32.00K 10-Q · filed 2024-08-08 | $65.00K 10-Q · filed 2024-08-08 | $97.00K derived: sum of 3 quarters · filed 2024-08-08 | $145.00K derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-09 | $65.00K derived: sum of 2 quarters · filed 2024-05-09 | $113.00K derived: sum of 3 quarters · filed 2024-05-09 | $145.00K derived: sum of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $80.00K derived: sum of 2 quarters · filed 2024-03-07 | $112.00K derived: sum of 3 quarters · filed 2024-03-07 | $145.00K 10-K · filed 2024-03-07 | ||||
| 2022-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $80.00K derived: sum of 2 quarters · filed 2023-11-09 | $113.00K 10-Q · filed 2023-11-09 | $140.00K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | $32.00K 10-Q · filed 2022-08-11 | $65.00K 10-Q · filed 2023-08-10 | $92.00K derived: sum of 3 quarters · filed 2023-05-11 | $125.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2022-03-31 | $28.00K 10-Q · filed 2023-05-11 | $32.00K 10-Q · filed 2022-05-12 | $60.00K derived: sum of 2 quarters · filed 2023-05-11 | $93.00K derived: sum of 3 quarters · filed 2023-05-11 | $126.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $65.00K derived: sum of 2 quarters · filed 2023-03-09 | $98.00K derived: sum of 3 quarters · filed 2023-03-09 | $210.00K 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-10 | $66.00K derived: sum of 2 quarters · filed 2022-08-11 | $178.00K 10-Q · filed 2022-11-10 | $314.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-11 | $145.00K 10-Q · filed 2022-08-11 | $281.00K derived: sum of 3 quarters · filed 2022-08-11 | $531.00K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $248.00K derived: sum of 2 quarters · filed 2022-05-12 | $498.00K derived: sum of 3 quarters · filed 2022-05-12 | $831.00K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $136.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $386.00K derived: sum of 2 quarters · filed 2022-03-10 | $719.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.22M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $250.00K 10-Q · filed 2021-11-10 | $583.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.08M 10-Q · filed 2021-11-10 | $1.58M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $333.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $831.00K 10-Q · filed 2021-08-12 | $1.33M derived: sum of 3 quarters · filed 2021-08-12 | $1.84M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $498.00K 10-Q · filed 2021-05-13 | $996.00K derived: sum of 2 quarters · filed 2021-05-13 | $1.50M derived: sum of 3 quarters · filed 2021-05-13 | $2.01M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.01M derived: sum of 2 quarters · filed 2021-03-11 | $1.51M derived: sum of 3 quarters · filed 2021-03-11 | $2.00M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $508.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $1.01M derived: sum of 2 quarters · filed 2020-11-04 | $1.50M 10-Q · filed 2020-11-04 | $1.98M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $507.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $992.00K 10-Q · filed 2020-08-06 | $1.47M derived: sum of 3 quarters · filed 2020-08-06 | $2.07M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $485.00K 10-Q · filed 2020-05-07 | $962.00K derived: sum of 2 quarters · filed 2020-05-07 | $1.56M derived: sum of 3 quarters · filed 2020-05-07 | $2.16M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.08M derived: sum of 2 quarters · filed 2020-03-12 | $1.68M derived: sum of 3 quarters · filed 2020-03-12 | $2.19M 10-K · filed 2020-03-12 | ||||
| 2018-09-30 | $600.00K 10-Q · filed 2018-11-08 | $1.20M derived: sum of 2 quarters · filed 2018-11-08 | $1.72M 10-Q · filed 2019-11-12 | $2.37M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-06-30 | $600.00K 10-Q · filed 2018-08-02 | $1.16M 10-Q · filed 2019-08-08 | $1.76M derived: sum of 3 quarters · filed 2019-05-09 | $2.37M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-03-31 | $582.00K 10-Q · filed 2019-05-09 | $1.17M derived: sum of 2 quarters · filed 2019-05-09 | $1.76M derived: sum of 3 quarters · filed 2019-05-09 | $2.37M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $583.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.18M derived: sum of 2 quarters · filed 2019-03-14 | $1.78M derived: sum of 3 quarters · filed 2019-03-14 | $2.35M 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $600.00K 10-Q · filed 2018-11-08 | $1.20M derived: sum of 2 quarters · filed 2018-11-08 | $1.77M 10-Q · filed 2018-11-08 | $2.44M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $600.00K 10-Q · filed 2018-08-02 | $1.18M 10-Q · filed 2018-08-02 | $1.84M derived: sum of 3 quarters · filed 2018-08-02 | $2.49M derived: sum of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | $602.00K 10-Q · filed 2018-05-10 | $1.24M derived: sum of 2 quarters · filed 2018-05-10 | $1.89M derived: sum of 3 quarters · filed 2018-05-10 | $2.87M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.28M derived: sum of 2 quarters · filed 2018-03-15 | $2.26M derived: sum of 3 quarters · filed 2018-03-15 | $3.58M 10-K · filed 2018-03-15 | ||||
| 2016-09-30 | $643.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.62M derived: sum of 2 quarters · filed 2017-11-09 | $2.94M 10-Q · filed 2017-11-09 | $4.25M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-06-30 | $978.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.29M 10-Q · filed 2017-08-09 | $3.61M derived: sum of 3 quarters · filed 2018-03-15 | $4.92M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2016-03-31 | $1.31M 10-Q · filed 2017-05-10 | $2.63M derived: sum of 2 quarters · filed 2018-03-15 | $3.94M derived: sum of 3 quarters · filed 2018-03-15 | $5.26M derived: sum of 4 quarters · filed 2018-03-15 | ||||
| 2015-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.63M derived: sum of 2 quarters · filed 2018-03-15 | $3.94M derived: sum of 3 quarters · filed 2018-03-15 | $5.26M 10-K · filed 2018-03-15 | ||||
| 2015-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $2.63M derived: sum of 2 quarters · filed 2016-11-04 | $3.94M 10-Q · filed 2016-11-04 | $7.20M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.63M 10-Q · filed 2016-08-09 | $5.88M derived: sum of 3 quarters · filed 2017-03-16 | $7.25M derived: sum of 4 quarters · filed 2017-03-16 | ||||
| 2015-03-31 | $1.31M 10-Q · filed 2016-05-10 | $1.31M 10-Q · filed 2015-05-08 | $4.57M derived: sum of 2 quarters · filed 2017-03-16 | $5.94M derived: sum of 3 quarters · filed 2017-03-16 | $7.31M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $4.62M derived: sum of 2 quarters · filed 2017-03-16 | $5.99M derived: sum of 3 quarters · filed 2017-03-16 | $7.36M 10-K · filed 2017-03-16 | $7.36M 10-K · filed 2015-03-11 | |||
| 2014-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.74M derived: sum of 2 quarters · filed 2015-11-09 | $4.10M 10-Q · filed 2015-11-09 | $4.10M 10-Q · filed 2014-11-07 | $5.47M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.74M 10-Q · filed 2015-08-10 | $2.74M 10-Q · filed 2014-08-11 | $4.10M derived: sum of 3 quarters · filed 2016-03-15 | $4.75M derived: sum of 4 quarters · filed 2016-03-15 | |||
| 2014-03-31 | $1.37M 10-Q · filed 2015-05-08 | $2.74M derived: sum of 2 quarters · filed 2016-03-15 | $3.38M derived: sum of 3 quarters · filed 2016-03-15 | $4.02M derived: sum of 4 quarters · filed 2016-03-15 | ||||
| 2013-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $2.01M derived: sum of 2 quarters · filed 2016-03-15 | $2.65M derived: sum of 3 quarters · filed 2016-03-15 | $3.30M 10-K · filed 2016-03-15 | $3.30M 10-K · filed 2014-03-17 | |||
| 2013-09-30 | $642.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.29M derived: sum of 2 quarters · filed 2014-11-07 | $1.93M 10-Q · filed 2014-11-07 | $2.61M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-06-30 | $642.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $1.29M 10-Q · filed 2014-08-11 | $1.97M derived: sum of 3 quarters · filed 2015-03-11 | $2.61M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2013-03-31 | $642.57K 10-Q · filed 2014-05-12 | $1.33M derived: sum of 2 quarters · filed 2015-03-11 | $1.97M derived: sum of 3 quarters · filed 2015-03-11 | $2.55M derived: sum of 4 quarters · filed 2015-03-11 | ||||
| 2012-12-31 | $682.59K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $1.32M derived: sum of 2 quarters · filed 2015-03-11 | $1.91M derived: sum of 3 quarters · filed 2015-03-11 | $2.45M 10-K · filed 2015-03-11 | ||||
| 2012-09-30 | $640.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $1.23M derived: sum of 2 quarters · filed 2013-11-12 | $1.76M 10-Q · filed 2013-11-12 | $2.13M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-06-30 | $587.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $1.12M 10-Q · filed 2013-08-09 | $1.49M derived: sum of 3 quarters · filed 2014-03-17 | $2.07M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2012-03-31 | $535.74K 10-Q · filed 2013-05-10 | $900.46K derived: sum of 2 quarters · filed 2014-03-17 | $1.49M derived: sum of 3 quarters · filed 2014-03-17 | $2.07M derived: sum of 4 quarters · filed 2014-03-17 | ||||
| 2011-12-31 | $364.72K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $949.68K derived: sum of 2 quarters · filed 2014-03-17 | $1.54M derived: sum of 3 quarters · filed 2014-03-17 | $1.99M 10-K · filed 2014-03-17 | ||||
| 2011-09-30 | $584.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.17M derived: sum of 2 quarters · filed 2012-11-09 | $1.63M 10-Q · filed 2012-11-09 | $2.10M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-06-30 | $585.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $1.04M 10-Q · filed 2012-08-09 | $1.51M derived: sum of 3 quarters · filed 2013-03-18 | $1.70M derived: sum of 4 quarters · filed 2013-03-18 | ||||
| 2011-03-31 | $456.15K 10-Q · filed 2012-05-10 | $925.44K derived: sum of 2 quarters · filed 2013-03-18 | $1.12M derived: sum of 3 quarters · filed 2013-03-18 | |||||
| 2010-12-31 | $469.28K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $661.78K derived: sum of 2 quarters · filed 2013-03-18 | $790.12K 10-K · filed 2013-03-18 | |||||
| 2010-09-30 | $192.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $320.83K 10-Q · filed 2011-11-08 | ||||||
| 2010-06-30 | $128.33K 10-Q · filed 2011-08-09 | |||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |